drugset / Trial / NCT03070054
LIA in Hip Arthroscopy Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The investigator's are conducting a randomized, blinded study to determine if the extra-capsular local infiltration analgesic (LIA) administration of 20ml 0.25% bupivacaine-epinephrine can improve the postoperative pain management of hip arthroscopy patients. Participants will be randomly assigned to the LIA group or non-LIA group prior to surgery. Participants, anesthesiologists and PACU nurses will be blinded to group assignment, however the surgeon administering the LIA will be unblinded.
Timeline
- Start
- 2016-06
- Primary completion
- 2020-03
- Completion
- 2020-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.25 % | — |
| Subject | Bupivacaine | Other / unclassified | 20 ml | — |
| Background | Epinephrine | Other / unclassified | — | — |
Indications
No indication recorded.